These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17035477)

  • 1. Complete response following preoperative chemotherapy for resectable non-small cell lung cancer.
    Serra M; Occhionero L; Galetta D
    Chest; 2006 Oct; 130(4):1284-5. PubMed ID: 17035477
    [No Abstract]   [Full Text] [Related]  

  • 2. Complete response following preoperative chemotherapy for resectable non-small cell lung cancer: accuracy of clinical assessment using the French trial database.
    Milleron B; Westeel V; Quoix E; Moro-Sibilot D; Braun D; Lebeau B; Depierre A;
    Chest; 2005 Sep; 128(3):1442-7. PubMed ID: 16162741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preoperative chemotherapy for non-small-cell lung cancer].
    Depierre A
    Rev Pneumol Clin; 2000 Jun; 56(3):173-4. PubMed ID: 10880943
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neoadjuvant chemotherapy in non-small cell lung cancer: current state and future].
    Mellas N; Elmesbahi O; Masbah O; Errihani H
    Bull Cancer; 2010 Feb; 97(2):211-23. PubMed ID: 20051349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy in non-small cell lung cancer: a standard approach?
    Felip E
    Tumori; 2000; 86(5 Suppl 1):S51-5. PubMed ID: 11195296
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction chemotherapy for resectable non-small-cell lung cancer.
    Patel JD; Blum MG; Argiris A
    Oncology (Williston Park); 2004 Nov; 18(13):1591-602; discussion 1602-3, 1606, 1611-2. PubMed ID: 15648293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant and induction chemotherapy in non-small cell lung cancer.
    Pirker R; Malayeri R; Huber H
    Ann Oncol; 1999; 10 Suppl 6():71-6. PubMed ID: 10676556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controversy in the treatment of non-small cell lung cancer. Timing of chemotherapy in relation to surgery: before or after?].
    Dediu M
    Pneumologia; 2004; 53(3):105-8. PubMed ID: 16108158
    [No Abstract]   [Full Text] [Related]  

  • 9. [On ''Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma: what is the answer?''].
    González Aragoneses F
    Arch Bronconeumol; 2007 Mar; 43(3):183-4; author reply 184. PubMed ID: 17386198
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction or neoadjuvant therapy in resectable non-small cell lung cancer.
    Langer CJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):34-9. PubMed ID: 10566609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative chemotherapy for non-small cell lung cancer.
    Depierre A; Westeel V; Jacoulet P
    Cancer Treat Rev; 2001 Apr; 27(2):119-27. PubMed ID: 11319850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
    Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L
    J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy in non small cell lung cancer-the UK experience.
    Waller DA
    Lung Cancer; 2001 Dec; 34 Suppl 3():S31-3. PubMed ID: 11740990
    [No Abstract]   [Full Text] [Related]  

  • 14. Pneumonectomy after chemotherapy: morbidity, mortality, and long-term outcome.
    Alifano M; Boudaya MS; Salvi M; Collet JY; Dinu C; Camilleri-Broët S; Régnard JF
    Ann Thorac Surg; 2008 Jun; 85(6):1866-72; discussion 1872-3. PubMed ID: 18498785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Induction therapy for non-small cell lung cancer].
    Matsumara A; Mori T
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1826-32. PubMed ID: 11729474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACR Appropriateness Criteria® on Induction and Adjuvant Therapy for Stage N2 Non-Small-Cell Lung Cancer: expert panel on radiation oncology-lung.
    Gopal RS; Dubey S; Rosenzweig KE; Chang JY; Decker R; Gewanter RM; Kong FM; Lally BE; Langer CJ; Lee HK; Movsas B
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):969-74. PubMed ID: 20813465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of randomized clinical trials on clinical practice regarding treatment of lung cancer.
    Milleron B; Debrix I; Gounand V; Wislez M
    J Thorac Oncol; 2007 May; 2(5):456. PubMed ID: 17473664
    [No Abstract]   [Full Text] [Related]  

  • 18. [Specificities of resectable Stage III non-small-cell lung cancer].
    Thibout Y; Cortot A; Mornex F
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S5-4S7. PubMed ID: 15687985
    [No Abstract]   [Full Text] [Related]  

  • 19. More questions about neoadjuvant chemotherapy in lung cancer.
    Vallières E
    Oncology (Williston Park); 2009 Sep; 23(10):892, 896. PubMed ID: 19839431
    [No Abstract]   [Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy in early-stage non-small cell lung cancer.
    Edelman MJ
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):229-35. PubMed ID: 12113028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.